Athanase Innovation AB (SE:ATIN)
:ATIN
Want to see SE:ATIN full AI Analyst Report?
Top Page
Athanase Innovation AB
(ATIN)
Select Model
Select Model
Rating:46Neutral
Price Target:
kr16.00
▼(-11.11% Downside)
Action:ReiteratedDate:05/06/26
The score is held down primarily by weak operating performance (declining revenue, negative margins) and poor cash generation, despite a conservative, low-debt balance sheet. Technicals are moderately supportive in the short term, but overbought signals and a still-weaker long-term trend limit the boost. Valuation is also constrained by ongoing losses (negative P/E) and no provided dividend yield.
Positive Factors
Low leverage and strong solvency
A near-zero debt profile materially reduces bankruptcy and refinancing risk over the medium term, giving management flexibility to fund operations or restructure without heavy interest burdens. This solvency buffer supports survival while the business works to restore profitability.
Negative Factors
Persistent negative profitability
Recurring negative margins indicate the core business model is not currently generating value; continued losses erode capital and limit the firm's ability to reinvest in growth. Without a durable path to positive margins, recovery will require structural changes to revenue or cost base.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and strong solvency
A near-zero debt profile materially reduces bankruptcy and refinancing risk over the medium term, giving management flexibility to fund operations or restructure without heavy interest burdens. This solvency buffer supports survival while the business works to restore profitability.
Read all positive factors
Athanase Innovation AB (ATIN) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr277.89M
Dividend YieldN/A
Average Volume (3M)56.00
Price to Earnings (P/E)―
Beta (1Y)0.41
Revenue Growth-68.02%
EPS Growth-242.58%
CountrySE
Employees31
SectorTechnology
Sector Strength88
IndustryAsset Management
Share Statistics
EPS (TTM)-2.99
Shares Outstanding19,297,642
10 Day Avg. Volume41
30 Day Avg. Volume56
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.81
Price to Sales (P/S)9.42
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Athanase Innovation AB Business Overview & Revenue Model
Company Description
Athanase Innovation AB is an alternative investment firm in Sweden. It invests in companies that operate in the forefront of robotics, digitalization, and automation. The company was incorporated in 2016 and is based in Stockholm, Sweden....
Athanase Innovation AB Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
72
Positive
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.86M | 176.83M | 40.60M | 6.38M | 7.06M |
| Gross Profit | -81.41M | 74.94M | 17.78M | -84.02M | -31.01M |
| EBITDA | -67.29M | 696.00K | -63.20M | -108.04M | -18.75M |
| Net Income | -57.62M | -19.64M | -56.26M | -114.53M | -26.55M |
Balance Sheet | |||||
| Total Assets | 481.31M | 551.97M | 683.18M | 827.25M | 918.70M |
| Cash, Cash Equivalents and Short-Term Investments | 245.39M | 310.64M | 457.25M | 644.36M | 746.92M |
| Total Debt | 0.00 | 0.00 | 328.00K | 422.00K | 515.00K |
| Total Liabilities | 53.90M | 67.20M | 49.09M | 35.36M | 11.30M |
| Stockholders Equity | 427.20M | 484.76M | 634.09M | 791.89M | 907.40M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -14.96M | -83.58M | -45.70M | -14.95M |
| Operating Cash Flow | -65.63M | -14.96M | -83.40M | -43.65M | -14.89M |
| Investing Cash Flow | -2.79M | -1.49M | 5.90M | -64.98M | -159.47M |
| Financing Cash Flow | 3.20M | -129.63M | -101.84M | -1.03M | 920.80M |
Athanase Innovation AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | kr466.37M | 1.67 | ― | 3.51% | 5.36% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | kr120.78M | 4.23 | ― | ― | 6.51% | 9.57% | |
49 Neutral | kr380.81M | -21.76 | ― | 8.78% | ― | -567.36% | |
47 Neutral | kr463.83M | -10.04 | ― | ― | 2.76% | 97.01% | |
46 Neutral | kr277.89M | -10.29 | ― | ― | -68.02% | -242.58% |
* Technology Sector Average
SE:ATIN
Athanase Innovation AB
16.20
-2.80
-14.74%
DE:7EU
Vo2 Cap Holding AB
0.17
0.02
13.61%
SE:INFREA
Infrea AB
14.50
1.73
13.55%
SE:NAXS
NAXS AB
37.50
-3.12
-7.69%
SE:SEAF
Seafire AB
7.22
2.95
69.09%
SE:STWK
Stockwik Forvaltning AB
16.30
-6.20
-27.56%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.